| Literature DB >> 35329066 |
Carlos Farinha1,2, Hélder Santos3, João Serrano4, Bárbara Oliveiros5, Fernanda M Silva1, Márcio Cascante-Rusenhack1,6, Ana Maria Teixeira1, José Pedro Ferreira1.
Abstract
Scientific evidence has shown that physical exercise is an effective way of improving several cardiovascular disease markers. However, few studies have tested its effectiveness when performed in aquatic environments. The purpose of this study was to test the impact of different aquatic exercise programs on the intima-media thickness of carotid arteries (IMT) and hemodynamic and biochemical markers of cardiovascular diseases in community-dwelling older persons. A total of 102 participants were randomly allocated into four groups: an aerobic exercise group (AerG) (n = 25, 71.44 ± 4.84 years); an aerobic interval group (IntG) (n = 28, 72.64 ± 5.22 years); a combined group (ComG) (n = 29, 71.90 ± 5.67 years); and a control group (CG) (n = 20, 73.60 ± 5.25 years). The AerG, IntG, and ComG participants took part in three different aquatic exercise programs for 28 weeks. The CG participants maintained their usual routines. All participants were evaluated for IMT, blood pressure, lipid profile, and MCP-1 and MIP-1α chemokines, pre- and post-intervention. Significant differences were found in the AerG for diastolic diameter (DD), in the IntG for peak systolic velocity (PSV), and in the ComG for DD and end-diastolic velocity (EDV). Regarding blood pressure, significant differences were found in AerG for systolic blood pressure (SBP) and diastolic blood pressure (DBP); in IntG for DBP; and in ComG for SBP, DBP, and heart rate (HR). Significant differences were found in the AerG and IntG for glucose (GLU). Lower plasma levels of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein (MIP-1α) were found in the AerG and in the ComG for MCP-1 after the intervention. Aquatic physical exercise appears to improve cardiovascular health, regardless of the type of the program adopted. Aerobic programs (combined and continuous aerobic exercises) seemed to have a more beneficial effect in reducing important cardiovascular risk markers.Entities:
Keywords: MCP-1; MDP-1α; ageing; aquatic environment; blood pressure; hemodynamic parameters; hydrogymnastics; intima-media thickness of the carotid arteries; lipid profile; physical exercise
Mesh:
Substances:
Year: 2022 PMID: 35329066 PMCID: PMC8950273 DOI: 10.3390/ijerph19063377
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Allocation process for the different groups: Continuous aerobic group (AerG); Aerobic interval group (IntG); Combined group (ComG); Control group (CG).
Figure 2Characteristics of the main part for the three physical exercise aquatic programs (continuous aerobic, interval aerobic, and combined).
Characterization of the baseline sample (M1).
| Characteristic | AerG ( | IntG ( | ComG ( | CG ( | |
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||
| AG (years) | 71.44 (4.8) | 72.64 (5.2) | 71.90 (5.7) | 73.60 (5.3) | 0.504 |
| Hgt (m) | 1.58 (0.7) | 1.56 (0.7) | 1.57 (0.7) | 1.60 (0.9) | 0.331 |
| WGT (kg) | 70.5 (8.1) | 71.3 (14.3) | 75.1 (11.0) | 75.5 (13.3) | 0.334 |
| BMI (kg/m2) | 28.20 (3.3) | 29.10 (4.8) | 30.80 (5.3) | 29.50 (5.8) | 0.272 |
| VF (%) | 11.0 (3.0) | 12.0 (3.0) | 13.0 (3.0) | 13.0 (6.0) | 0.128 |
| FM (%) | 38.9 (7.3) | 41.0 (6.7) | 40.3 (9.8) | 34.9 (10.9) | 0.134 |
| LBM (%) | 26.5 (4.3) | 24.5 (3.0) | 25.5 (4.3) | 27.7 (4.7) | 0.079 |
| 2 m-ST (no of steps) | 80.9 (17.4) | 71.5 (16.5) | 81.6 (19.2) | 74.3 (18.9) | 0.069 |
| CSR-R (cm) | −0.5 (6.6) | −3.7 (10.6) | −3.5 (7.8) | −7.6 (9.7) | 0.099 |
| CSR-L (cm) | 0.6 (7.2) | −3.9 (9.9) | −5.8 (9.9) | −3.5 (7.3) | 0.054 |
| BS-R (cm) | −9.9 (10.4) | −11.9 (11.5) | −14.3 (9.7) | −16.6 (9.9) | 0.157 |
| BS-L (cm) | −14.4 (7.2) | −17.4 (8.6) | −21.0 (10.8) | −20.6 (10.7) | 0.056 |
| TUG (s) | 6.1 (1.1) | 7.4 (1.8) | 7.4 (3.0) | 6.8 (1.7) | 0.110 |
| 30 s-CS (reps/30 s) | 15.0 (3.0) | 13.0 (4.0) | 13.0 (3.0) | 15.0 (5.0) | 0.185 |
| 30 s-AC (reps/30 s) | 21.0 (6.0) | 17.0 (7.0) | 20.0 (5.0) | 19.0 (6.0) | 0.119 |
| HG-R (kg) | 22.0 (6.0) | 21.0 (9.0) | 21.0 (9.0) | 24.0 (9.0) | 0.411 |
| HG-L (kg) | 21.0 (6.0) | 20.0 (9.0) | 21.0 (9.0) | 21.0 (10.0) | 0.578 |
Note: Age (AG); height (Hgt); weight (Wgt); body mass index (BMI); visceral fat (VF); fat mass (FM); lean body mass (LBM); two-minute step test (2 m-ST); chair sit and reach test—right (CSR-R); chair sit and reach test—left (CSR-L); back scratch test—right (BS-R); back scratch test—left (BS-L); timed up and go test (TUG); chair stand test (30 s-CS); hand grip test—right (HG-R); hand grip test—left (HG-L).
Figure 3Relationships between SBP-DD-R and SBP-SD-L, and HDL-DD-R and HLD-SD-L. Notes: systolic blood pressure (SBP), diastolic diameter—right (DD-R), systolic diameter—left (SD-L), high-density lipoprotein (HDL).
IMT and Hemodynamic parameters results.
| AerG | IntG | ComG | CG | Time × Group (M1) | Time × Group (M2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | Time | M1 | M2 | Time | M1 | M2 | Time | M2 | M1 | Time | |||
| IMT-L | 0.07 | 0.07 | 0.293 | 0.08 | 0.07 | 0.376 | 0.07 | 0.07 | 0.707 | 0.07 | 0.07 | 0.979 | 0.989 | 0.501 |
| SD-L | 0.69 | 0.67 | 0.177 | 0.65 | 0.65 | 0.539 | 0.66 | 0.64 | 0.105 | 0.65 | 0.66 | 0.088 | 0.605 | 0.546 |
| DD-L | 0.64 | 0.62 | 0.423 | 0.61 | 0.59 | 0.105 | 0.63 | 0.60 | 0.037 ** | 0.61 | 0.62 | 0.558 | 0.640 | 0.264 |
| PSV-L | 76.79 | 80.31 | 0.242 | 82.51 | 77.21 | 0.104 | 79.38 | 78.73 | 0.315 | 77.28 | 80.24 | 0.097 | 0.508 | 0.835 |
| EDV-L | 19.28 | 19.95 | 0.397 | 20.8 | 20.26 | 0.581 | 22.38 | 19.97 | 0.027 * | 19.7 | 22.41 | 0.003 * | 0.090 | 0.443 |
| IMT-R | 0.08 | 0.07 | 0.808 | 0.08 | 0.07 | 0.055 | 0.08 | 0.07 | 0.205 | 0.08 | 0.08 | 0.308 | 0.654 | 0.698 |
| SD-R | 0.70 | 0.68 | 0.178 | 0.66 | 0.65 | 0.381 | 0.67 | 0.66 | 0.249 | 0.68 | 0.66 | 0.353 | 0.519 | 0.758 |
| DD-R | 0.66 | 0.63 | 0.039 * | 0.62 | 0.61 | 0.282 | 0.63 | 0.60 | 0.029 * | 0.62 | 0.63 | 0.813 | 0.316 | 0.543 |
| PSV-R | 74.6 | 74.1 | 0.904 | 74.63 | 66.23 | 0.024 * | 81.23 | 77.25 | 0.087 | 74.27 | 73.11 | 0.763 | 0.136 | 0.106 |
| EDV-R | 19.55 | 18.89 | 0.716 | 19.39 | 18.26 | 0.186 | 20.74 | 19.18 | 0.064 | 18.43 | 19.27 | 0.432 | 0.169 | 0.910 |
| SBP | 134 | 128 | 0.013 * | 135 | 132 | 0.184 | 138 | 133 | 0.018 ** | 137 | 132 | 0.093 | 0.798 | 0.535 |
| DBP | 77 | 73 | 0.002 * | 76 | 73 | 0.046 * | 79 | 75 | 0.004 * | 78 | 78 | 0.950 | 0.399 | 0.099 |
| HR | 71 | 69 | 0.279 | 69 | 67 | 0.115 | 74 | 70 | 0.010 ** | 73 | 71 | 0.467 | 0.417 | 0.268 |
Note: Intima–media thickness—left (IMT-L); systolic diameter—left (SD-L); diastolic diameter—left (DD-L); peak systolic velocity—left (PSV-L); end-diastolic velocity—left (EDV-L); Intima-media thickness—right (IMT-R); systolic diameter—right (SD-R); diastolic diameter—right (DD-R); peak systolic velocity—right (PSV-R); end-diastolic velocity—right (EDVR); systolic blood pressure (SBP); diastolic blood pressure (DBP); heart rate (HR) * Result obtained through T-Student test; ** result obtained through Wilcoxon test.
Figure 4Images of the carotid artery of a study participant at different times of assessment: before the intervention (M1), the participant had an intima and media thickness of the carotid artery (IMT) of 0.10 cm; after the intervention (M2), a reduction in the IMT to 0.06 cm was verified.
Biochemical marker results.
| AerG | IntG | ComG | CG | Time × | Time × | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | Time | M1 | M2 | Time | M1 | M2 | Time | M1 | M2 | Time | |||
| GLU | 94 (27) | 89 (22) | 0.006 ** | 95 (18) | 90 (17) | 0.041 ** | 98 (25) | 95 (24) | 0.309 | 97 (20) | 99 (18) | 0.449 | 0.728 | 0.112 |
| TC | 184 | 185 | 0.935 | 174 | 172 | 0.650 | 182 | 178 | 0.346 | 176 | 177 | 0.757 | 0.512 | 0.381 |
| HDL | 58 (14) | 59 (12) | 0.586 | 58 (15) | 56 (15) | 0.175 | 58 (11) | 59 (13) | 0.478 | 57 (11) | 55 (11) | 0.111 | 0.907 | 0.582 |
| AI | 3.29 | 3.33 | 0.653 | 3.17 | 3.25 | 0.249 | 3.23 | 3.27 | 0.566 | 3.21 | 3.67 | 0.003 * | 0.598 | 0.033 † |
| LDL | 106 | 108 | 0.712 | 95 (27) | 95 (24) | 0.855 | 103 | 100 | 0.498 | 97 (25) | 97 (25) | 0.989 | 0.338 | 0.226 |
| TG | 102 | 101 | 0.903 | 105 | 104 | 0.682 | 107 | 104 | 0.503 | 116 | 119 | 0.478 | 0.393 | 0.191 |
| MCP-1 | 141.74 | 82.45 | 0.001 ** | 80.43 | 63.42 | 0.059 | 231.79 | 193.44 | 0.033 ** | 72.76 | 54.34 | 0.093 | 0.000 † | 0.000 † |
| MIP-1α | 93.09 | 91.04 | 0.009 ** | 96.19 | 96.45 | 0.179 | 110.49 | 110.43 | 0.214 | 90.90 | 90.96 | 0.546 | 0.000 † | 0.000 † |
Note: Glucose (GLU); cholesterol total (TC); high-density lipoprotein (HDL); atherogenic index (AI); low-density lipoprotein (LDL); triglycerides (TG); monocyte chemoattractant protein-1 (MPC-1); macrophage inflammatory protein (MIP-1α). * Result obtained through T-Student test; ** result obtained through Wilcoxon test; † results obtained through ANOVA.